TipRanks
Go Ultimate55% OFF

Bastide le Confort Medical (1DJ) Stock Price & Analysis

1DJ Stock Chart & Stats

€18.04€0.04(0.22%)
At close: 1:00 AM GMT+1
€17.5€20€22.5€2531 Jul3 Sep21 Oct
Day’s Range
EUR 18.04 - EUR 18.28
52-Week Range
EUR 17.48 - EUR 27.10
Previous Close
EUR 18.00
Volume
N/A
Average Volume (3M)
3
Market Cap
EUR 135.29M
Enterprise Value
EUR 487.51M
Total Cash (Recent Filing)
EUR 48.21M
Total Debt (Recent Filing)
EUR 299.13M
Price to Earnings (P/E)
2.3
Beta
0.43
Next Earnings
Mar 24, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Long-term Revenue Expansion

Revenue growth over the full period indicates that Bastide has expanded its business base despite an uneven path. The 2026 rebound supports continued demand for its homecare offering and provides a platform for improving earnings if growth becomes more consistent.

Positive Operating Cash Flow

Consistently positive operating cash flow demonstrates that the core homecare and medical-equipment activities generate cash even when reported earnings are volatile. This supports ongoing operations, debt servicing, and selective investment without relying entirely on external financing.

Resilient Operating Profitability

A broadly stable EBITDA margin suggests the operating model has retained underlying profitability across several years. The sharp 2026 net-margin recovery further indicates that earnings power can improve materially when adverse factors affecting prior-year results ease.

Bears Say

Elevated Leverage

Despite recent debt reduction and higher equity, leverage remains a significant constraint on financial flexibility. Elevated debt relative to equity can increase financing pressure, restrict investment choices, and make the business more sensitive to any sustained operating weakness.

Weak Cash Conversion

Positive operating cash flow has not translated consistently into discretionary free cash flow or cash earnings. Weak conversion can limit the funds available for deleveraging, expansion, and shareholder returns, making reported profit less dependable as a measure of financial strength.

Uneven Revenue And Margin Profile

The uneven revenue trajectory and pronounced gross-margin swing indicate that profitability is not yet fully predictable. Such volatility can complicate planning, weaken confidence in normalized earnings, and leave results vulnerable to changes in business mix or cost structure.

Bastide le Confort Medical News

1DJ FAQ

What was Bastide le Confort Medical’s price range in the past 12 months?
Bastide le Confort Medical lowest stock price was €17.48 and its highest was €27.10 in the past 12 months.
What is Bastide le Confort Medical’s market cap?
Bastide le Confort Medical’s market cap is €135.29M.
When is Bastide le Confort Medical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bastide le Confort Medical’s earnings last quarter?
Bastide le Confort Medical released its earnings results on Oct 21, 2026. The company reported €3.904 earnings per share for the quarter.
Is Bastide le Confort Medical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Bastide le Confort Medical pay dividends?
Bastide le Confort Medical does not currently pay dividends.
What is Bastide le Confort Medical’s EPS estimate?
Bastide le Confort Medical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bastide le Confort Medical have?
Bastide le Confort Medical has 7,365,078 shares outstanding.
What happened to Bastide le Confort Medical’s price movement after its last earnings report?
Bastide le Confort Medical reported an EPS of €3.904 in its last earnings report. Following the earnings report the stock price went up 0.555%.
Which hedge fund is a major shareholder of Bastide le Confort Medical?
Currently, no hedge funds are holding shares in DE:1DJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology